Not applicableWithdrawnNCT03935308What this trial is testingPhase I Study MR-guided SBRT to PCaWho this might be right forLow or Intermediate Risk Prostate Cancer Henry Ford Health System
Testing effectiveness (Phase 2)Study completedNCT03828838What this trial is testingLutetium-177-PSMA-617 in Low Volume Metastatic Prostate CancerWho this might be right forProstate Neoplasm Radboud University Medical Center 10
Testing effectiveness (Phase 2)Ended earlyNCT01928485What this trial is testingGreen Tea Extract in Treating Patients With Low-Risk Prostate CancerWho this might be right forStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer Sanjay Gupta PhD 6
Not applicableActive Not RecruitingNCT01877070What this trial is testingDecision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close AlliesWho this might be right forLow Risk Prostate Cancer Memorial Sloan Kettering Cancer Center 541
Testing effectiveness (Phase 2)Study completedNCT00283829What this trial is testingImmunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate CancerWho this might be right forProstate Cancer University of Washington 30
Not applicableLooking for participantsNCT05668351What this trial is testingStereotactic Ablative Radiation Therapy for Prostate CancerWho this might be right forProstate Cancer Medical University of South Carolina 36
Not applicableLooking for participantsNCT04146077What this trial is testingActive Surveillance for Low Risk Prostate CancerWho this might be right forProstate CancerProstate Adenocarcinoma I.M. Sechenov First Moscow State Medical University 100
Not applicableNot Yet RecruitingNCT06915909What this trial is testingRobotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) TrialWho this might be right forProstate Cancer (Adenocarcinoma)Prostate Cancer (Post Prostatectomy)Prostate Cancer Surgery+3 more East and North Hertfordshire NHS Trust 40
Not applicableUnknownNCT03979573What this trial is testingProspective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate CancerWho this might be right forProstate Cancer Heinrich-Heine University, Duesseldorf 90
Not applicableStudy completedNCT00897793What this trial is testingGrowth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+2 more Vanderbilt-Ingram Cancer Center 25
Large-scale testing (Phase 3)UnknownNCT00295802What this trial is testingAblatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate CancerWho this might be right forProstate Cancer EDAP TMS S.A. 141
Not applicableStudy completedNCT06199986What this trial is testingDeADT - Living Well With Prostate CancerWho this might be right forProstate Cancer University of Michigan 50
Not applicableLooking for participantsNCT05722392What this trial is testingSafety and Efficacy of Two-step Radical ProstatectomyWho this might be right forProstate Cancer Sun Yat-sen University 30
Testing effectiveness (Phase 2)WithdrawnNCT01802307What this trial is testingFocal Therapy for Prostate CancerWho this might be right forProstatic NeoplasmsProstate Cancer University of Maryland, Baltimore
Not applicableLooking for participantsNCT06866041What this trial is testingBiological Markers and Advanced Imaging for Prostate Cancer Progression in Active SurveillanceWho this might be right forLow-Risk Prostate Cancer Università Vita-Salute San Raffaele 74
Large-scale testing (Phase 3)Study completedNCT06601205What this trial is testingFinasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.Who this might be right forProstate CancerProstatic Intraepithelial Neoplasia Ente Ospedaliero Ospedali Galliera 125
Early research (Phase 1)Ended earlyNCT05369000What this trial is testingTrial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate CancerWho this might be right forMetastatic Castration Resistant Prostate Cancer Lava Therapeutics 96
Testing effectiveness (Phase 2)Study completedNCT01759771What this trial is testingVitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized TrialWho this might be right forProstate Cancer VA Office of Research and Development 130
Not applicableNot Yet RecruitingNCT07130682What this trial is testingTwo-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II TrialWho this might be right forProstate Cancer Patients Treated by Radiotherapy Hong Kong Sanatorium & Hospital 35
Large-scale testing (Phase 3)Active Not RecruitingNCT04513717What this trial is testingTwo Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialWho this might be right forProstate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8 NRG Oncology 2,753